Beranda › Kanker Metastatik › North Carolina › Charlotte
Uji klinis Kanker Metastatik di Charlotte, NC
11 studi untuk Kanker Metastatik mencari peserta di lokasi sekitar Charlotte (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- Levine Cancer Institute, Charlotte
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Menerima pesertaFase 1/2
- Atrium Health Levine Cancer Institute, Charlotte
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Menerima pesertaFase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi jauhnya
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Menerima pesertaFase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi jauhnya
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Menerima pesertaFase 1/2
- Levine Cancer Institute, Charlotte
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Menerima pesertaFase 1
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Menerima pesertaFase 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Uji klinis Kanker Metastatik di kota lain
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Studi lain di Charlotte
- Kanker (semua jenis)27 studi
- Kanker Payudara22 studi
- Mieloma Multipel21 studi
- Kanker Paru Non-Sel Kecil19 studi
- Leukemia Mieloid Akut16 studi
- Obesitas16 studi
- Kelebihan Berat Badan15 studi
- Kanker Kolorektal13 studi
- Kanker Ovarium12 studi
- Gagal Jantung11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher10 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.